SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056964
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:57
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grts-20240331.htm   iXBRL 10-Q 1904316
2 EX-31.1 grts-ex31_1.htm EX-31.1 17669
3 EX-31.2 grts-ex31_2.htm EX-31.2 17660
4 EX-32.1 grts-ex32_1.htm EX-32.1 15237
  Complete submission text file 0000950170-24-056964.txt   9994217

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT grts-20240331.xsd EX-101.SCH 1639355
84 EXTRACTED XBRL INSTANCE DOCUMENT grts-20240331_htm.xml XML 1844305
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 24930727
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)